甲状腺癌

Haugen BR, Alexander EK, Bible KC, et al; American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016 Jan;26(1):1-133.

• 全文
• 摘要

Cobin RH, Gharib H, Bergman DA, et al; Thyroid Carcinoma Task Force. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. Endocr Pract. 2001 May-Jun;7(3):202-20.

• 全文
• 摘要

Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules - 2016 update. Endocr Pract. 2016;22(Suppl 1):1-60.

• 全文
• 摘要

1.  Gimm O. Thyroid cancer. Cancer Lett. 2001 Feb 26;163(2):143-56.

• 摘要

2.  Haugen BR, Alexander EK, Bible KC, et al; American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016 Jan;26(1):1-133.

• 全文
• 摘要

3.  Hundahl SA, Fleming ID, Fremgen AM, et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer.1998 Dec 15;83(12):2638-48.

• 全文
• 摘要

4.  Bertagna F, Treglia G, Piccardo A, et al. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. J Clin Endocrinol Metab. 2012 Nov;97(11):3866-75.

• 摘要

5.  Phillips JS, Pledger DR, Hilger AW. Rapid thyrotoxicosis in anaplastic thyroid carcinoma. J Laryngol Otol. 2007 Jul;121(7):695-7.

• 摘要

6.  Cobin RH, Gharib H, Bergman DA, et al; Thyroid Carcinoma Task Force. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. Endocr Pract. 2001 May-Jun;7(3):202-20.

• 全文
• 摘要

7.  Pellegriti G, Frasca F, Regalbuto C, et al. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:965212.

• 全文
• 摘要

8.  Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2014. Bethesda, MD: National Cancer Institute; 2017.

• 全文

9.  Cancer Research UK. UK thyroid cancer incidence statistics: 2014. 2017. [internet publication].

• 全文

10.  Grinspoon S, Seely E, eds. 3 perspectives on thyroid cancer: what's new in treatment and research. Endocr News. 2005;30:10-15.

11.  Kim TH, Park YJ, Lim JA. The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis. Cancer. 2012 Apr 1;118(7):1764-73.

• 全文
• 摘要

12.  Segev DL, Umbricht C, Zeiger MA. Molecular pathogenesis of thyroid cancer. Surg Oncol. 2003 Aug;12(2):69-90.

• 摘要

13.  Patel KN, Singh B. Genetic considerations in thyroid cancer. Cancer Control. 2006 Apr;13(2):111-8.

• 摘要

14.  Simon D, Korber C, Krausch M, et al. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. Eur J Nucl Med Mol Imaging. 2002 Jun;29(6):775-82.

• 摘要

15.  Sherman SI. Thyroid carcinoma. Lancet. 2003 Feb 8;361(9356):501-11.

• 摘要

16.  Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules - 2016 update. Endocr Pract. 2016;22(Suppl 1):1-60.

• 全文
• 摘要

17.  Spallek L, Krille L, Reiners C, et al. Adverse effects of iodine thyroid blocking: a systematic review. Radiat Protn Dosimetry. 2012 Jul;150(3):267-77.

• 摘要

18.  American College of Radiology. ACR-AIUM-SPR-SRU practice parameter for the performance of a thyroid and parathyroid ultrasound examination. 2014. [internet publication].

• 全文

19.  Novoa E, Gürtler N, Arnoux A, et al. Role of ultrasound-guided core-needle biopsy in the assessment of head and neck lesions: a meta-analysis and systematic review of the literature. Head Neck. 2012 Oct;34(10):1497-503.

• 摘要

20.  Webb RC, Howard RS, Stojadinovic A, et al. The utility of serum thyroglobulin measurement at the time of remnant ablation for predicting disease-free status in patients with differentiated thyroid cancer: a meta-analysis involving 3947 patients. J Clin Endocrinol Metab. 2012 Aug;97(8):2754-63.

• 摘要

21.  Sebag F, Vaillant-Lombard J, Berbis J, et al. Shear wave elastography: a new ultrasound imaging mode for the differential diagnosis of benign and malignant thyroid nodules. J Clin Endocrinol Metab. 2010 Dec;95(12):5281-8.

• 摘要

22.  Rago T, Scutari M, Santini F, et al. Real-time elastosonography: useful tool for refining the presurgical diagnosis in thyroid nodules with indeterminate or nondiagnostic cytology. J Clin Endocrinol Metab. 2010 Dec;95(12):5274-80.

• 摘要

23.  Wu LM, Gu HY, Qu XH, et al. The accuracy of ultrasonography in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: a meta-analysis. Eur J Radiol. 2012 Aug;81(8):1798-805.

• 摘要

24.  Mekel M, Nucera C, Hodin RA, et al. Surgical implications of B-RafV600E mutation in fine-needle aspiration of thyroid nodules. Am J Surg. 2010 Jul;200(1):136-43.

• 摘要

25.  Hegedus L. Can elastography stretch our understanding of thyroid histomorphology? J Clin Endocrinol Metab. 2010 Dec;95(12):5213-5.

• 摘要

26.  Hershman JM, Cheng S, Gianoukakis, et al. Update in thyroidology. 2010. J Clin Endocrinol Metab. 2011 Jan;96(1):9-14.

• 摘要

27.  Nikiforov YE. Molecular diagnostics of thyroid tumors. Arch Pathol Lab Med. 2011 May;135(5):569-77.

• 全文
• 摘要

28.  Balasubramanian SP, Harrison BJ. Systematic review and meta-analysis of sentinel node biopsy in thyroid cancer. Br J Surg. 2011 Mar;98(3):334-44.

• 摘要

29.  Shaha AR. Advances in the management of thyroid cancer. Int J Surg. 2005;3(3):213-20.

• 摘要

30.  Lang BH, Lo CY, Chan WF, et al. Staging systems for papillary thyroid carcinoma: a review and comparison. Ann Surg. 2007 Mar;245(3):366-78.

• 摘要

31.  Lang BH, Lo CY, Chan WF, et al. Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre. Endocr Relat Cancer. 2007 Mar;14(1):29-42.

• 摘要

32.  US Preventive Services Task Force. Screening for thyroid cancer: US Preventive Services Task Force recommendation statement. JAMA. 2017 May 9;317(18):1882-1887.

• 全文
• 摘要

33.  Perros P, Boelaert K, Colley S, et al; British Thyroid Association. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf). 2014;81 Suppl 1:1-122.

• 全文
• 摘要

34.  White ML, Gauger PG, Doherty GM, et al. Central lymph node dissection in differentiated thyroid cancer. World J Surg. 2007 May;31(5):895-904.

• 摘要

35.  Shan CX, Zhang W, Jiang DZ, et al. Routine central neck dissection in differentiated thyroid carcinoma: a systematic review and meta-analysis. Laryngoscope. 2012 Apr;122(4):797-804.

• 摘要

36.  Zetoune T, Keutgen X, Buitrago D, et al. Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis. Ann Surg Oncol. 2010 Dec;17(12):3287-93.

• 摘要

37.  Hughes DT, Doherty GM. Central neck dissection for papillary thyroid cancer. Cancer Control. 2011 Apr;18(2):83-8.

• 摘要

38.  Samraj K, Gurusamy KS. Wound drains following thyroid surgery. Cochrane Database Syst Rev. 2007;(4):CD006099.

• 摘要

39.  Inabnet WB. Surgical management of thyroid cancer. Endocr Pract. 2000 Nov-Dec;6(6):465-8.

• 摘要

40.  Fallahi B, Beiki D, Takavar A, et al. Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma: a large randomized clinical trial. Nucl Med Commun. 2012 Mar;33(3):275-82.

• 摘要

41.  Mallick U, Harmer C, Yap B, et al. Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer. New Engl J Med. 2012 May 3;366(18):1674-85.

• 全文
• 摘要

42.  Sugitani I, Fujimoto Y. Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: a prospective controlled study. Surgery. 2011 Dec;150(6):1250-7.

• 摘要

43.  Flynn RW, Bonellie SR, Jung RT, et al. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab. 2010;95:186-193.

• 摘要

44.  Brose MS, Nutting CM, Jarzab B, et al; DECISION Investigators. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial. Lancet. 2014 Jul 26;384(9940):319-28.

• 全文
• 摘要

45.  Schlumberger M, Tahara M, Wirth LJ, et al. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med. 2015 Feb 12;372(7):621-30.

• 全文
• 摘要

46.  Wells SA Jr, Robinson BG, Gagel RF, et al. Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial. J Clin Oncol. 2012 Jan 10;30(2):134-41.

• 全文
• 摘要

47.  Frampton JE. Vandetanib: in medullary thyroid cancer. Drugs. 2012 Jul 9;72(10):1423-36.

• 摘要

48.  Nagaiah G, Hossain A, Mooney CJ, et al. Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment. J Oncol. 2011;2011:542358.

• 全文
• 摘要

49.  Salerno P, De Falco V, Tamburrino A, et al. Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cells. J Clin Endocrinol Metab. 2010 Jan;95(1):450-5.

• 摘要

50.  Ball DW. Selectively targeting mutant BRAF in thyroid cancer. J Clin Endocrinol Metab. 2010 Jan;95(1):60-1.

• 摘要

51.  Elisei R, Schlumberger MJ, Müller SP, et al. Cabozantinib in progressive medullary thyroid cancer. J Clin Oncol. 2013 Oct 10;31(29):3639-46.

• 全文
• 摘要

52.  Fan LJ, Jiang J. Present and future of robot-assisted endoscopic thyroid surgery. Chin Med J (Engl). 2012 Mar;125(5):926-31.

• 摘要

53.  Vini L, Harmer C. Management of thyroid cancer. Lancet Oncol. 2002 Jul;3(7):407-14.

• 摘要

54.  Widder S, Pasieka JL. Primary thyroid lymphomas. Curr Treat Options Oncol. 2004 Aug;5(4):307-13.

• 摘要

55.  Toft AD. Clinical practice. Subclinical hyperthyroidism. N Engl J Med. 2001;345:512-516.

• 摘要

56.  Genton CY, Dutoit M, Portmann L, et al. Pathologic fracture of the femur neck as first manifestation of a minute columnar cell carcinoma of the thyroid gland. Pathol Res Pract. 1998;194(12):861-3;

• 摘要

57.  Schroeder PR, Haugen BR, Pacini F, et al. A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal. J Clin Endocrinol Metab. 2006 Mar;91(3):878-84.

• 摘要

58.  Yoo J, Cosby R, Driedger A. Preparation with recombinant humanized thyroid-stimulating hormone before radioiodine ablation after thyroidectomy: a systematic review. Curr Oncol. 1991 Jan;11(1):401-11.

• 摘要

59.  Ma C, Xie J, Liu W, Wang G, et al. Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer. Cochrane Database Syst Rev. 2010;(11):CD008302.

• 摘要

60.  Royal College of Physicians (UK). Evidence-based indications for the use of PET-CT in the UK 2016. May 2016. [internet publication].

• 全文

61.  American Thyroid Association Taskforce On Radioiodine Safety, Sisson JC, Freitas J, et al. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I: practice recommendations of the American Thyroid Association. Thyroid. 2011 Apr;21(4):335-46.

• 全文
• 摘要